The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects.
about
Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort studyCongenital ventricular septal defects and prenatal exposure to cyclooxygenase inhibitorsIndices of oxidative stress in pregnancy with fetal growth restrictionSignal generation and clarification: use of case-control data.Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study.Analgesic use during pregnancy and risk of infant leukaemia: a Children's Oncology Group studyMajor malformations after first trimester exposure to aspirin and NSAIDs.Case-control analysis of maternal prenatal analgesic use and cardiovascular malformations: Baltimore-Washington Infant StudyPregnant women and non-steroidal anti-inflammatory drugs: knowledge, perception and drug consumption pattern during pregnancy in ethiopiaPrescribing without evidence - pregnancy.Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE).Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation.Aspirin Use in Women: Current Perspectives and Future Directions.Acute myocardial infarction during pregnancy and puerperium: a review.Aspirin for Prevention of Preeclampsia.
P2860
Q28199350-D49E496A-D798-4E50-8CFF-C33015CB005DQ28199711-B624FE4F-842D-43F7-B5C5-72337FF7ACF5Q28218877-D8F00A85-F889-476D-8BE3-0594D4109AA6Q30658394-ED111C6A-7AFF-48D1-821F-B25A245088A8Q34512958-522CA836-6248-4E30-A103-6E2E176F1C23Q34627781-B4597885-E4D9-49CC-BAE8-56867856790DQ35085118-5AAEC0BE-64F3-415B-98BC-B94E6EADC75AQ35525008-A5EA7331-1409-48A3-838A-781F245563E3Q35811049-E13364B0-8B3B-4544-B557-C8B8610E8BBEQ36336002-3F627D32-2F98-493B-8491-1F2E962E3D8AQ37063617-500956CE-35B8-4F27-A721-C739BE4C8C19Q38209622-77A865E0-0886-4F87-9828-77C7E7CC8947Q38799794-250F4456-51F8-449A-A718-A96DBAC08D0AQ41036162-C0A73E15-A734-4BD7-B8F8-DA157BADFE82Q43281151-B532DD11-A429-4D7F-9C57-4CC3C601DE00
P2860
The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
The relation of aspirin use du ...... to congenital cardiac defects.
@en
type
label
The relation of aspirin use du ...... to congenital cardiac defects.
@en
prefLabel
The relation of aspirin use du ...... to congenital cardiac defects.
@en
P1476
The relation of aspirin use du ...... to congenital cardiac defects.
@en
P2093
P304
P356
10.1056/NEJM198912143212404
P407
P577
1989-12-01T00:00:00Z